Successful Use of an Advanced Hybrid Closed-loop System in a Patient With Type 3c Pancreatogenic Diabetes Secondary to Nesidioblastosis

Can J Diabetes. 2023 Mar;47(2):193-196. doi: 10.1016/j.jcjd.2022.09.117. Epub 2022 Sep 17.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Diabetes Mellitus, Type 1* / drug therapy
  • Humans
  • Insulin / therapeutic use
  • Insulin Infusion Systems
  • Nesidioblastosis*

Substances

  • Insulin